Atrion (NASDAQ:ATRI) will post its quarterly earnings results after the market closes on Wednesday, February 21st.
Shares of Atrion (NASDAQ:ATRI) opened at $547.00 on Tuesday. The firm has a market cap of $1,012.96, a PE ratio of 30.30 and a beta of 0.73. Atrion has a 12 month low of $459.05 and a 12 month high of $694.00.
Separately, BidaskClub lowered shares of Atrion from a “sell” rating to a “strong sell” rating in a research note on Tuesday, January 9th.
ILLEGAL ACTIVITY NOTICE: This report was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/20/atrion-atri-scheduled-to-post-quarterly-earnings-on-wednesday.html.
Atrion Company Profile
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.
Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.